Advertisement
HALO or OGEN or RDUS
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HALO’s FA Score shows that 0 FA rating(s) are green whileOGEN’s FA Score has 0 green FA rating(s), and RDUS’s FA Score reflects 0 green FA rating(s).
- HALO’s FA Score: 0 green, 5 red.
- OGEN’s FA Score: 0 green, 5 red.
- RDUS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HALO’s TA Score shows that 4 TA indicator(s) are bullish while OGEN’s TA Score has 4 bullish TA indicator(s), and RDUS’s TA Score reflects 4 bullish TA indicator(s).
- HALO’s TA Score: 4 bullish, 6 bearish.
- OGEN’s TA Score: 4 bullish, 4 bearish.
- RDUS’s TA Score: 4 bullish, 4 bearish.
Price Growth
HALO (@Biotechnology) experienced а +1.43% price change this week, while OGEN (@Biotechnology) price change was -10.67% , and RDUS (@Steel) price fluctuated +0.07% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.
The average weekly price growth across all stocks in the @Steel industry was +0.58%. For the same industry, the average monthly price growth was +4.41%, and the average quarterly price growth was +10.09%.
Reported Earning Dates
HALO is expected to report earnings on Nov 10, 2025.
OGEN is expected to report earnings on May 09, 2025.
RDUS is expected to report earnings on Oct 23, 2025.
Industries' Descriptions
@Biotechnology (+2.69% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Steel (+0.58% weekly)The steel industry includes manufacturers of steel and steel-related products. Companies use iron ore and scrap steel to produce steel. The industry also includes companies involved in mining and marketing of steel products. Along with serving some of the domestic markets, U.S. steel output has, over the years, been used by international economies as well. Competition from imported steel has also increased over time. The industry could be susceptible to business cycles, since the element is an important input in industrial production. Some of the globally-renowned steel behemoths include Nucor Corporation, Vale, and ArcelorMittal SA.
| HALO | OGEN | RDUS | |
| Capitalization | 6.97B | 1.1M | 848M |
| EBITDA | 705M | -10.11M | -200.1M |
| Gain YTD | 18.385 | -87.905 | 101.533 |
| P/E Ratio | 15.05 | N/A | N/A |
| Revenue | 1.08B | 0 | 2.74B |
| Total Cash | 748M | 3.42M | 5.44M |
| Total Debt | 1.51B | 2.55M | 562M |
HALO | OGEN | RDUS | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 4 | 50 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 37 | 100 | 71 | |
SMR RATING 1..100 | 100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 54 | 98 | 37 | |
P/E GROWTH RATING 1..100 | 100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 50 | 8 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HALO's Valuation (50) in the Biotechnology industry is in the same range as OGEN (50) and is in the same range as RDUS (50). This means that HALO's stock grew similarly to OGEN’s and similarly to RDUS’s over the last 12 months.
HALO's Profit vs Risk Rating (37) in the Biotechnology industry is somewhat better than the same rating for RDUS (71) and is somewhat better than the same rating for OGEN (100). This means that HALO's stock grew somewhat faster than RDUS’s and somewhat faster than OGEN’s over the last 12 months.
HALO's SMR Rating (100) in the Biotechnology industry is in the same range as RDUS (100) and is in the same range as OGEN (100). This means that HALO's stock grew similarly to RDUS’s and similarly to OGEN’s over the last 12 months.
RDUS's Price Growth Rating (37) in the Biotechnology industry is in the same range as HALO (54) and is somewhat better than the same rating for OGEN (98). This means that RDUS's stock grew similarly to HALO’s and somewhat faster than OGEN’s over the last 12 months.
RDUS's P/E Growth Rating (100) in the Biotechnology industry is in the same range as HALO (100) and is in the same range as OGEN (100). This means that RDUS's stock grew similarly to HALO’s and similarly to OGEN’s over the last 12 months.
| HALO | OGEN | RDUS | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 66% | 1 day ago 85% | 1 day ago 65% |
| Stochastic ODDS (%) | 1 day ago 56% | 1 day ago 79% | 1 day ago 71% |
| Momentum ODDS (%) | 1 day ago 72% | 1 day ago 89% | 1 day ago 71% |
| MACD ODDS (%) | N/A | 1 day ago 90% | 1 day ago 79% |
| TrendWeek ODDS (%) | 1 day ago 75% | 1 day ago 90% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 90% | 1 day ago 70% |
| Advances ODDS (%) | 6 days ago 77% | 9 days ago 81% | 7 days ago 74% |
| Declines ODDS (%) | 16 days ago 68% | 1 day ago 90% | 21 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 60% | 1 day ago 77% | 1 day ago 81% |
| Aroon ODDS (%) | 1 day ago 64% | 1 day ago 90% | 1 day ago 60% |
Advertisement
RDUS and
Correlation & Price change
A.I.dvisor indicates that over the last year, RDUS has been loosely correlated with ZEUS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RDUS jumps, then ZEUS could also see price increases.
| Ticker / NAME | Correlation To RDUS | 1D Price Change % | ||
|---|---|---|---|---|
| RDUS | 100% | N/A | ||
| ZEUS - RDUS | 52% Loosely correlated | -3.40% | ||
| IIIN - RDUS | 47% Loosely correlated | -2.16% | ||
| STLD - RDUS | 46% Loosely correlated | -3.27% | ||
| RYI - RDUS | 44% Loosely correlated | -3.46% | ||
| MLI - RDUS | 42% Loosely correlated | -1.49% | ||
More | ||||